Ask AI
ProCE Banner Activity

Evidence-Based Care in Atopic Dermatitis: Practical Considerations for IL-13 Inhibitors for Moderate to Severe Disease

Podcast Episodes

In this episode, dermatology experts discuss patient candidacy and treatment advancement strategies for using IL-13 inhibitors in atopic dermatitis, with key take-home points illustrated through a detailed patient case.

Released: June 25, 2025

Expiration: June 24, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National Eczema Association.

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

National Eczema Association

ProCE Banner

Practicing Clinicians Exchange, LLC

ProCE Banner

Disclosure

Primary Author

Daniel Butler, MD: consultant/advisor/speaker: Galderma, Leo, Sanofi.

Shawn G. Kwatra, MD, has no relevant financial relationships to disclose.